DE: Substance Abuse, Chemical Depence, and Drug DiversionPage 2 of 12

Delaware: Substance Abuse, Chemical Dependency, and Drug Diversion

The Delaware Board of Nursing requires RNs and LPNs to complete at least three of your required contact hours in the area of substance abuse. This course fulfills that requirement.

image: substance abuse

For mail order or to view/download a printable copy of this course, PDF icon please click here.

Author: Sara Wilson, BA


Contact hours: 3
Expiration date: October 1, 2024
Course price: $29

Course Summary

Evidence-based information about the problem of chemical dependency in the workplace, warning signs of substance use disorder, drug diversion and controlled substances, including safeguards to prevent diversion, misuse, abuse, addiction, and overdose deaths.

Criteria for Successful Completion

Study the course material, achieve a score of 80% or higher on the post test (the post test can be repeated if a learner scores less than 80%), complete the course evaluation, and pay where required. No partial credit will be awarded.


To find specific accreditations or approvals, click here

Course Objectives

When you finish this course you will be able to:

  1. Describe the 5 Schedules of medications under the Controlled Substances Act and give examples of each.
  2. Compare and contrast acute and chronic pain and discuss the trends in treatment of chronic pain.
  3. Identify the demographic of drug abusers in U.S. society and cite five groups from whom they may get drugs.
  4. State 7 symptoms of drug withdrawal from opioids at and least 4 best practice recommendations by the Medical Society of Delaware.
  5. Name 3 categories of risk factors for opioid abuse and addiction and demonstrate ability to create a treatment plan for an abuser.
  6. Explain informed consent and name 5 elements set forth by the Federation of Medical Boards.
  7. List the 7 assessment tools for monitoring ongoing opioid therapy.
  8. State at least 5 precautions to follow when tapering the patient off of opioids.
  9. Describe Delaware’s Prescription Drug Monitoring Programs (PDMPs) and explain drug take-back programs.